Renin–Angiotensin System Antagonists and Clinical Outcomes in Stable Coronary Artery Disease Without Heart Failure

Study Questions:

Is use of angiotensin-converting enzyme inhibitor (ACEI) or angiotensin-II receptor blocker (ARB) associated with lower rates of cardiovascular events in patients with stable coronary artery disease (CAD), but without heart failure (HF)?